康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688185 康希诺

已收盘 11-12 15:00:00

{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":73.76,"timestamp":1794466800000,"preClose":75.99,"halted":0,"volume":6942319,"delay":0,"changeRate":-0.0293,"floatShares":113999999,"shares":247000000,"eps":0.1204,"marketStatus":"已收盘","change":-2.23,"latestTime":"11-12 15:00:00","open":75.5,"high":77.3,"low":73.63,"amount":523000000,"amplitude":0.0483,"askPrice":73.76,"askSize":34,"bidPrice":73.75,"bidSize":17,"shortable":0,"etf":0,"ttmEps":0.1204,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":75.99,"symbolType":"stock_kcb","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":83.59,"lowLimit":68.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247043801,"isCdr":false,"pbRate":3.64,"roa":"--","peRate":612.624585,"roe":"0.33%","epsLYR":0.11,"committee":0.628986,"marketValue":18222000000,"turnoverRate":0.0607,"status":1,"afterMarket":{"amount":221280,"volume":3000,"close":73.76,"buyVolume":1173,"sellVolume":0,"time":1794468837746,"indexStatus":"已收盘 11-12 15:30:00","preClose":75.99},"hkstockBrief":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":25.86,"timestamp":1794470886006,"preClose":26.7,"halted":0,"volume":2593953,"delay":0,"premium":"-70.19"},"floatMarketCap":8436000000},"requestUrl":"/m/hq/s/688185","defaultTab":"news","newsList":[{"id":"2681813356","title":"康希诺（688185）11月6日主力资金净卖出658.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681813356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681813356?lang=zh_cn&edition=full","pubTime":"2026-11-07 09:22","pubTimestamp":1794014567,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月6日收盘，康希诺报收于74.2元，下跌5.44%，换手率7.21%，成交量8.25万手，成交额6.15亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入6281.91万元，融资偿还4998.21万元，融资净买入1283.7万元，连续3日净买入累计4869.06万元。康希诺主营业务：创新疫苗的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700010221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681911881","title":"康希诺（688185）11月5日主力资金净买入3990.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681911881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681911881?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:12","pubTimestamp":1793923937,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月5日收盘，康希诺报收于78.47元，上涨10.21%，换手率10.19%，成交量11.65万手，成交额9.04亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入9462.18万元，融资偿还6673.66万元，融资净买入2788.52万元。康希诺主营业务：创新疫苗的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680472203","title":"康希诺（688185）披露A股限制性股票激励计划部分股票作废事项，11月03日股价下跌8.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680472203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680472203?lang=zh_cn&edition=full","pubTime":"2026-11-03 22:04","pubTimestamp":1793714696,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，康希诺报收于66.14元，较前一交易日下跌8.63%，最新总市值为163.39亿元。近日，康希诺生物股份公司发布H股公告披露：截至2026年10月31日，A股限制性股票激励计划中，作废26,300股限制性股票，相关安排可能导致发行的股份总数相应调整。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300044951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03130","02827","82823","83130","82843","BK1610","159982","688185","BK0239","02846","82846","02843","03188","82822","399300","BK1147","07233","02822","02823","83188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680498657","title":"破发股康希诺跌8.63% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2680498657","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680498657?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:06","pubTimestamp":1793696763,"startTime":"0","endTime":"0","summary":"中国经济网北京11月3日讯 康希诺 今日收报66.14元，跌幅8.63%。该股目前处于破发状态。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261103/32414630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1147","LU1255011170.USD","LU1997245177.USD","LU1720050803.USD","LU2580892862.HKD","LU1328615791.USD","LU2148510915.USD","LU0405327148.USD","LU2289578879.USD","BK0196","LU1146622755.USD","BK1521","LU1781817850.SGD","BK1516","LU1655091616.SGD","BK0276","LU1064130708.USD","LU1997244956.HKD","BK1564","LU2580892789.USD","LU1820825898.SGD","600030","LU0405327494.USD","BK0188","LU2495084118.USD","688185","BK0028","BK0012","LU1064131003.USD","LU1997245094.SGD","LU1794554557.SGD","BK0183","BK0239","LU1580142542.USD","IPOS","06030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680754982","title":"康希诺：关于变更持续督导保荐代表人的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2680754982","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680754982?lang=zh_cn&edition=full","pubTime":"2026-11-02 20:01","pubTimestamp":1793620860,"startTime":"0","endTime":"0","summary":"证券日报网讯11月2日，康希诺发布公告称，公司于近日收到中信证券股份有限公司出具的《关于更换保荐代表人的函》。徐峰林先生因工作变动，不再继续担任公司持续督导工作的保荐代表人。为保证后续工作的有序进行，根据相关规定，中信证券委派王天祺女士接替徐峰林先生担任公司首次公开发行股票并在科创板上市项目的持续督导保荐代表人，负责公司后续持续督导工作，继续履行相关职责。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611023918949010.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611023918949010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679773884","title":"破发股康希诺跌5.74% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2679773884","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679773884?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:28","pubTimestamp":1793269686,"startTime":"0","endTime":"0","summary":"中国经济网北京10月29日讯 康希诺 今日收报73.80元，跌幅5.74%。该股目前处于破发状态。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261029/32411207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["06030","LU1720050803.USD","BK0276","BK0183","BK1147","BK1516","LU2148510915.USD","LU1820825898.SGD","LU1255011170.USD","BK1521","LU0405327494.USD","BK0239","LU1580142542.USD","LU0405327148.USD","IPOS","LU1997245177.USD","LU1997245094.SGD","LU1655091616.SGD","LU2289578879.USD","LU1781817850.SGD","LU1997244956.HKD","LU2580892862.HKD","BK0028","BK0012","688185","LU1064130708.USD","600030","LU2495084118.USD","LU2580892789.USD","LU1794554557.SGD","BK1564","BK0188","LU1064131003.USD","LU1328615791.USD","BK0196","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678291480","title":"康希诺（688185）10月27日主力资金净卖出5201.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678291480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678291480?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:47","pubTimestamp":1793148429,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，康希诺报收于72.1元，下跌5.87%，换手率5.83%，成交量6.66万手，成交额4.92亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入4699.3万元，融资偿还5100.33万元，融资净偿还401.03万元。康希诺主营业务：创新疫苗的研发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678110409","title":"图解康希诺三季报：第三季度单季净利润同比下降39.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678110409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678110409?lang=zh_cn&edition=full","pubTime":"2026-10-28 00:51","pubTimestamp":1793119879,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺2026年三季报显示，前三季度公司主营收入8.82亿元，同比上升27.4%；归母净利润1629.13万元，同比上升12.82%；扣非净利润-4497.72万元，同比上升45.72%；其中2026年第三季度，公司单季度主营收入3.32亿元，同比上升7.17%；单季度归母净利润1701.21万元，同比下降39.08%；单季度扣非净利润507.14万元，同比上升66.56%；负债率26.85%，投资收益1188.87万元，财务费用2710.1万元，毛利率77.76%。财报数据概要请见下图:本文数据来源于康希诺2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800002290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678179634","title":"康希诺：前三季度净利润同比增长12.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678179634","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678179634?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:59","pubTimestamp":1793098750,"startTime":"0","endTime":"0","summary":"南财智讯10月27日电，康希诺发布三季度报告，前三季度公司实现营业收入8.82亿元，同比增长27.40%；归属于上市公司股东的净利润1629.13万元，同比增长12.82%。自2026年1月1日起，公司国内销售的疫苗产品不再适用生物制品简易征收办法下3%的征收率，改为适用一般计税方法下13%的增值税税率，依托于日益丰富的商业化产品组合及海外业务逐步放量，营业收入实现增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610273910198856.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610273910198856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678121882","title":"破发股康希诺跌5.87% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2678121882","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678121882?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:22","pubTimestamp":1793089323,"startTime":"0","endTime":"0","summary":"中国经济网北京10月27日讯 康希诺 今日收报72.10元，跌幅5.87%。该股目前处于破发状态。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261027/32408949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2495084118.USD","BK0196","LU1997245177.USD","LU1997244956.HKD","BK1564","LU2580892862.HKD","688185","600030","BK0239","BK1521","BK0183","LU0405327148.USD","LU1720050803.USD","LU2289578879.USD","BK1147","BK0188","BK0012","LU1781817850.SGD","06030","LU0405327494.USD","LU1580142542.USD","BK0028","LU2148510915.USD","LU2580892789.USD","LU1820825898.SGD","BK1516","IPOS","LU1794554557.SGD","LU1655091616.SGD","LU1064130708.USD","LU1064131003.USD","LU1255011170.USD","LU1146622755.USD","LU1997245094.SGD","LU1328615791.USD","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677918276","title":"康希诺（688185）10月22日主力资金净卖出1.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677918276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677918276?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:27","pubTimestamp":1792715233,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月22日收盘，康希诺报收于74.3元，下跌6.74%，换手率6.65%，成交量7.6万手，成交额5.81亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入4603.59万元，融资偿还9359.24万元，融资净偿还4755.64万元。康希诺主营业务：创新疫苗的研发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300007600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677072937","title":"破发股康希诺跌6.74% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2677072937","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677072937?lang=zh_cn&edition=full","pubTime":"2026-10-22 16:06","pubTimestamp":1792656362,"startTime":"0","endTime":"0","summary":"中国经济网北京10月22日讯 康希诺 今日收报74.30元，跌幅6.74%。该股目前处于破发状态。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261022/32405299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1521","LU1255011170.USD","LU1064130708.USD","LU1997245177.USD","LU1146622755.USD","LU1064131003.USD","LU1794554557.SGD","BK1564","LU2495084118.USD","LU1655091616.SGD","LU0405327148.USD","BK0239","BK0028","BK0012","BK0188","BK0183","LU2148510915.USD","LU2580892862.HKD","06030","LU1781817850.SGD","600030","LU1328615791.USD","LU1720050803.USD","688185","BK0276","LU0405327494.USD","LU2289578879.USD","LU1997244956.HKD","IPOS","BK1147","BK0196","LU1997245094.SGD","LU1820825898.SGD","LU2580892789.USD","BK1516","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665765","title":"康希诺：定期报告截止日及其后的股东人数披露不早于当期定期报告的披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665765?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:45","pubTimestamp":1792485919,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺10月20日在投资者关系平台上答复投资者关心的问题。如您有查阅公司股东人数的需求，可于公司定期报告披露后再次提问；或向公司投资者关系邮箱发送邮件取得进一步联系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000024957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676637690","title":"康希诺（688185）10月19日主力资金净卖出9719.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676637690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676637690?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:30","pubTimestamp":1792456217,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，康希诺报收于80.06元，下跌3.44%，换手率8.15%，成交量9.32万手，成交额7.47亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入8308.23万元，融资偿还7848.64万元，融资净买入459.58万元。康希诺主营业务：创新疫苗的研发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000005332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675375791","title":"康希诺（688185）10月14日主力资金净卖出1.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675375791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675375791?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:31","pubTimestamp":1792024271,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，康希诺报收于84.0元，下跌4.59%，换手率7.25%，成交量8.29万手，成交额7.11亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入4998.73万元，融资偿还8137.77万元，融资净偿还3139.05万元。康希诺主营业务：创新疫苗的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500007161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675957613","title":"康希诺（688185）10月13日主力资金净卖出1.20亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675957613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675957613?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:26","pubTimestamp":1791937609,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，康希诺报收于88.04元，下跌3.06%，换手率10.06%，成交量11.5万手，成交额10.1亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入1.02亿元，融资偿还8892.24万元，融资净买入1337.56万元。康希诺主营业务：创新疫苗的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674487329","title":"破发股康希诺跌7.76% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2674487329","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674487329?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:12","pubTimestamp":1791796329,"startTime":"0","endTime":"0","summary":"中国经济网北京10月12日讯 康希诺 今日收报90.82元，跌幅7.76%。该股目前处于破发状态。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261012/32393790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1997244956.HKD","LU1328615791.USD","LU1997245177.USD","LU1781817850.SGD","LU2495084118.USD","BK0196","LU1794554557.SGD","06030","LU1064130708.USD","LU1146622755.USD","LU0405327148.USD","BK1147","LU2289578879.USD","LU1655091616.SGD","BK0188","LU1997245094.SGD","688185","BK1564","LU1064131003.USD","LU1255011170.USD","LU0405327494.USD","LU1580142542.USD","LU1820825898.SGD","LU2580892789.USD","BK1521","BK0276","LU1720050803.USD","BK0239","BK0028","BK0012","IPOS","BK1516","BK0183","600030","LU2148510915.USD","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671678361","title":"今日涨停！688185回应mRNA热点：胶质母细胞瘤等肿瘤疫苗仍在早期研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671678361","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671678361?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:45","pubTimestamp":1790779500,"startTime":"0","endTime":"0","summary":"9月30日，康希诺(SH688185)涨停，当日收盘价达102.64元/股，市值254亿元。当日晚间，康希诺公告称，公司股票于2026年9月28日、9月29日及9月30日连续三个交易日内日收盘价格涨幅偏离值累计超 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260930/c680424439.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260930/c680424439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["159646","BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205420","title":"康希诺最新公告：正在进行mRNA预防用疫苗及治疗性生物制品的开发以及相关递送系统的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671205420?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:51","pubTimestamp":1790765462,"startTime":"0","endTime":"0","summary":"康希诺(688185.SH)发布股票交易异常波动公告，公司关注到近期市场上关于mRNA技术的发展，海外mRNA肿瘤疫苗临床阶段性数据发布或计划公开。mRNA平台是公司布局的技术平台之一，公司正在进行mRNA预防用疫苗及治疗性生物制品的开发，以及相关递送系统的开发。治疗领域方面，公司正在推进mRNA疫苗用于治疗胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发工作，以及InVivoCAR相关疗法的开发，目前均处于早期阶段。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000031654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159646","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671057522","title":"创新药一路狂涨！688185，直线20cm涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2671057522","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671057522?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:23","pubTimestamp":1790763780,"startTime":"0","endTime":"0","summary":"9日最后一个交易日，A股三大指数今日涨跌不一，截至收盘，上证指数涨0.31%，深证成指跌0.11%，创业板指跌0.23%，北证50涨0.7%，科创50指数跌2.51%。全市场成交额14500亿元，较上日放量285亿元，全市场超2800只个股下跌。创新药板块涨幅第一，康希诺触及20cm涨停，贝瑞基因、康辰药业、昭衍新药、奥赛康等多股涨停，三元基因、义翘神州涨超10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["IBBQ","BK0239","688185","MEDX","159992","BK1574","LNGR","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794495402838,"stockEarnings":[{"period":"1week","weight":0.0673},{"period":"1month","weight":-0.1633},{"period":"3month","weight":0.3397},{"period":"6month","weight":0.2669},{"period":"1year","weight":0.0065},{"period":"ytd","weight":0.2091}],"compareEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0307},{"period":"3month","weight":-0.0627},{"period":"6month","weight":-0.11},{"period":"1year","weight":-0.0805},{"period":"ytd","weight":-0.0726}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康希诺生物股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","registeredCapital":"24704万元","survey":"　　康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司的主要产品是脑膜炎球菌结合疫苗、肺炎球菌结合疫苗、组分百白破疫苗、重组脊髓灰质炎疫苗等。公司已被国家工业和信息化部评为专精特新“小巨人”企业，入选天津市猎豹企业。公司自主研发的“多糖蛋白结合疫苗关键技术及产业化”项目荣获天津市科学技术进步一等奖。获奖项目所攻克的核心为多糖蛋白结合技术，是当前全球领先的疫苗技术之一。","listedPrice":209.71},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}